Based on their annotation details, 6 of these 7 DEGs were associated with myeloid cell activity (BATF3, COL11A1, IL6, MMP1, PDZK1IP1, and TNFRSF10C), 4 with common signaling pathways (BATF3, COL11A1, IL6, and SOX11), and 3 each with the killing of cancer cells (IL6, SOX11, and TNFRSF10C) and myeloid compartment pathways (COL11A1, MMP1, and PDZK1IP1). This evidence concerns the gene IL6 and cancer.